<p>The figure shows the classification of patients in the study and the inclusion criteria. TB patients included those who were alive at TB diagnosis with culture-positive, pulmonary TB (in both episodes for recurrent TB patients), and, had completed anti-TB therapy. Patients were excluded if initial isoniazid or rifampin drug susceptibility test results were not documented, or, if the date of treatment completion or date of initiation of treatment for a second TB episode was not documented. Percentages were calculated using the previous group (previous box) as the denominator. One hundred forty eight persons in this study population had late recurrent TB, and 23,369 had one episode of TB (see text for details). TB = tuberculosis.</p
<p>*Missing inf°rmation in 24 case-control pairs</p>†<p>Susceptibility of isolates to isoniazid, rif...
*<p>2 months of rifampicin (R), isoniazid (H), pyrazinamide (Z), ethambutol (E), followed by 4 month...
BackgroundRecent data have demonstrated that healthcare use after treatment for respiratory tubercul...
Inclusion criteria were study populations of patients with predominantly pulmonary tuberculosis, cer...
Contains fulltext : 19113_duraoftra.pdf (publisher's version ) (Open Access)Inclus...
<p>RCT: Randomized Controlled Trial; Pros: prospective; Ret: retrospective PTB: pulmonary tuberculos...
<p>TB, tuberculosis; BCG, Bacillus Calmette Guérin; TST, tuberculin skin test; IGRA, interferon-gamm...
*<p>Including both bacteriologically confirmed and clinical cases of TB.</p>**<p>Number of missing o...
<p>Footnote to Figure1: PTB = Pulmonary Tuberculosis *PTB patients classified as new by the TB clini...
<p>We initially enrolled 1294 pulmonary, smear-positive tuberculosis patients into the study. One pa...
<div><p>Cases with treatment outcomes other than treatment success or treatment default were exclude...
<p>Data are numbers (%) unless otherwise stated. ART, antiretroviral therapy; TB, tuberculosis; IQR,...
<p>A total of 226 subjects suspected to have active tuberculosis (ATB) were recruited and 182 were e...
<p>Footnotes: TB: tuberculosis; HIV: human immunodeficiency virus; TST: tuberculin skin test with a ...
<p>The figure shows the cumulative hazards of recurrent TB in the study population during the study ...
<p>*Missing inf°rmation in 24 case-control pairs</p>†<p>Susceptibility of isolates to isoniazid, rif...
*<p>2 months of rifampicin (R), isoniazid (H), pyrazinamide (Z), ethambutol (E), followed by 4 month...
BackgroundRecent data have demonstrated that healthcare use after treatment for respiratory tubercul...
Inclusion criteria were study populations of patients with predominantly pulmonary tuberculosis, cer...
Contains fulltext : 19113_duraoftra.pdf (publisher's version ) (Open Access)Inclus...
<p>RCT: Randomized Controlled Trial; Pros: prospective; Ret: retrospective PTB: pulmonary tuberculos...
<p>TB, tuberculosis; BCG, Bacillus Calmette Guérin; TST, tuberculin skin test; IGRA, interferon-gamm...
*<p>Including both bacteriologically confirmed and clinical cases of TB.</p>**<p>Number of missing o...
<p>Footnote to Figure1: PTB = Pulmonary Tuberculosis *PTB patients classified as new by the TB clini...
<p>We initially enrolled 1294 pulmonary, smear-positive tuberculosis patients into the study. One pa...
<div><p>Cases with treatment outcomes other than treatment success or treatment default were exclude...
<p>Data are numbers (%) unless otherwise stated. ART, antiretroviral therapy; TB, tuberculosis; IQR,...
<p>A total of 226 subjects suspected to have active tuberculosis (ATB) were recruited and 182 were e...
<p>Footnotes: TB: tuberculosis; HIV: human immunodeficiency virus; TST: tuberculin skin test with a ...
<p>The figure shows the cumulative hazards of recurrent TB in the study population during the study ...
<p>*Missing inf°rmation in 24 case-control pairs</p>†<p>Susceptibility of isolates to isoniazid, rif...
*<p>2 months of rifampicin (R), isoniazid (H), pyrazinamide (Z), ethambutol (E), followed by 4 month...
BackgroundRecent data have demonstrated that healthcare use after treatment for respiratory tubercul...